This cluster is too small to drive stock price action or signal management sentiment. No action warranted; monitor Form 4 filings in the run-up to the next quarterly earnings for any material changes in C-suite ownership patterns.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 7 $55.22entry
- T+1 · 4mo ago −1.68%α −1.38% · $54.29
- T+5 · 4mo ago −6.56%α −7.11% · $51.60
- T+20 · 4mo ago −10.05%α −13.21% · $49.67
- T+60 · 7w ago −26.62%α −28.62% · $40.52
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Alkermes executives, the EVP/CLO and the EVP R&D/CMO, sold a combined $537K in open-market shares near $52-54, representing ~0.006% of the $9.1B market cap. The CMO's sales coincided with option exercises at a $19.34 strike, consistent with routine post-vesting diversification rather than a bearish signal. At this proportionality, the cluster is trivial relative to company size.
Key Financial Metrics
Key Facts
- EVP/CLO Gaffin sold 2,034 shares at $54.03, proceeds ~$110K on market
- EVP R&D/CMO Hopkinson sold 9,000 open-market shares total at $51.46-$52.13, proceeds ~$464K
- CMO Hopkinson simultaneously exercised 10,000 derivative shares at $19.34 strike ($96.7K cost basis)
- Total open-market sales: $537K, or ~0.006% of $9.1B market cap
- Insider selling cluster is far below the 0.1% materiality threshold
- CMO's exercise-and-sell pattern indicates routine vesting-related liquidity, not a bearish view
Financial Impact
Total insider open-market sales of $537K represent ~0.006% of Alkermes' $9.1B market capitalization, negligible in dollar and relative terms
Risk Factors
- No material risk identified from this cluster, sales are routine and trivial in size
- If a surprise 8-K filing follows with negative news, the timing of this diversified sale could attract scrutiny, but the dollar amounts are far too small to suggest informed selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALKS-1783408670002 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers